PH and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Recorded on Oct. 28, 2021
Ivan Robbins, M.D., discusses CTEPH, highlights the importance of diagnosis and shares treatment options for individuals with pulmonary hypertension (PH) related to chronic thromboembolic disease. Hear Dr. Robbins’s contributions to the evaluation and treatment of PH as director at the Adult Pulmonary Vascular Center and interim medical director of the Lung Transplant Program at Vanderbilt University.
About the Speaker
Ivan Robbins, M.D.
Ivan Robbins, M.D., is the director of the Adult Pulmonary Vascular Center and the interim medical director of the Lung Transplant Program at Vanderbilt University. He joined Vanderbilt in 1997 after completing a fellowship in pulmonary and critical care medicine at Vanderbilt University Medical Center. Dr. Robbins received his medical degree from Case Western Reserve School of Medicine and completed his residence at Metro Health Medical Center in Cleveland, Ohio. His educational tenure includes 23 years of studying pulmonary vascular disease and participating in over 20 published clinical trials that evaluated and treated individuals with CTEPH.
“Pulmonary Hypertension & Chronic Thromboembolic Pulmonary Hypertension”
“What You Need to Know After a Pulmonary Embolism”
PHA thanks Janssen Pharmaceuticals for its Diamond sponsorship and Bayer HealthCare for its Platinum sponsorship of the PHA Connects Fund, which provides support to this PHA Live event.